Drugs / Iodoform
Iodoform
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 42 trials | ||||||
| Phase 4 | NCT03741894 | Sep 2018 → Sep 2020 | alveolar periostitis, impacted teeth, multiple, pulpitis | University of Pecs | Unknown | No outcome recorded |
| Phase 4 | NCT03084601 | Mar 2017 → Jan 2018 | dental pulp necrosis | Mahmoud M Saadoon | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT06755502 Comparator | Aug 2025 → Oct 2026 expected | pulpitis | Cairo University | Not yet recruiting | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Iodoform | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03084601 ↗ |
| Known as | Iodoformum | ChEMBL registry synonym — accepted as the source's own label CHEMBL1451116 ↗ |
| Known as | NSC-26251 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1451116 ↗ |
| Modality | Small molecule | — CHEMBL1451116 ↗ |
| Route | Other | “mixture of calcium hydroxide and iodoform, placed in pulp chamber only one time” NCT03084601 ↗ |